GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (NSE:ABBOTINDIA) » Definitions » PB Ratio

Abbott India (NSE:ABBOTINDIA) PB Ratio : 15.80 (As of Jun. 08, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Abbott India PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-08), Abbott India's share price is ₹27494.80. Abbott India's Book Value per Share for the quarter that ended in Mar. 2024 was ₹1,740.71. Hence, Abbott India's PB Ratio of today is 15.80.

Good Sign:

Abbott India Ltd stock PB Ratio (=14.87) is close to 2-year low of 13.48

The historical rank and industry rank for Abbott India's PB Ratio or its related term are showing as below:

NSE:ABBOTINDIA' s PB Ratio Range Over the Past 10 Years
Min: 4.08   Med: 10.65   Max: 19.53
Current: 15.54

During the past 13 years, Abbott India's highest PB Ratio was 19.53. The lowest was 4.08. And the median was 10.65.

NSE:ABBOTINDIA's PB Ratio is ranked worse than
97.05% of 949 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs NSE:ABBOTINDIA: 15.54

During the past 12 months, Abbott India's average Book Value Per Share Growth Rate was 16.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 12.40% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 11.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 17.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Abbott India was 30.00% per year. The lowest was 2.70% per year. And the median was 15.35% per year.

Back to Basics: PB Ratio


Abbott India PB Ratio Historical Data

The historical data trend for Abbott India's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India PB Ratio Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.50 12.24 13.34 14.70 15.58

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.70 - 15.84 - 15.58

Competitive Comparison of Abbott India's PB Ratio

For the Drug Manufacturers - General subindustry, Abbott India's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's PB Ratio distribution charts can be found below:

* The bar in red indicates where Abbott India's PB Ratio falls into.



Abbott India PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Abbott India's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=27494.80/1740.711
=15.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Abbott India  (NSE:ABBOTINDIA) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Abbott India PB Ratio Related Terms

Thank you for viewing the detailed overview of Abbott India's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (NSE:ABBOTINDIA) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (NSE:ABBOTINDIA) Headlines

No Headlines